Vidipha Central Pharmaceutical JSC (VDP) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Vidipha Central Pharmaceutical JSC

Why is Vidipha Central Pharmaceutical JSC ?

Flat results in Jun 25

ROCE(HY) Lowest at 9.13%
INVENTORY TURNOVER RATIO(HY) Lowest at 1.98%
OPERATING PROFIT(Q) Lowest at VND 19,971.44 MM

With ROE of 9.08%, it has a fair valuation with a 0.00 Price to Book Value

Over the past year, while the stock has generated a return of 33.52%, its profits have risen by 0.1%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Vidipha Central Pharmaceutical JSC should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Vidipha Central Pharmaceutical JSC for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Vidipha Central Pharmaceutical JSC

34.29%

0.91

44.92%

Vietnam VN Ho Chi Minh Index

29.95%

1.61

21.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.58%

EBIT Growth (5y)

10.05%

EBIT to Interest (avg)

4.71

Debt to EBITDA (avg)

0.68

Net Debt to Equity (avg)

-0.20

Sales to Capital Employed (avg)

1.00

Tax Ratio

20.61%

Dividend Payout Ratio

76.87%

Pledged Shares

Institutional Holding

ROCE (avg)

11.37%

ROE (avg)

10.13%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

-1.43

EV to EBITDA

-1.03

EV to Capital Employed

-0.18

EV to Sales

-0.12

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

9.08%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

Bearish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

OPERATING CASH FLOW(Y)

Highest at VND 203,120.14 MM

RAW MATERIAL COST(Y)

Fallen by -11.81% (YoY

CASH AND EQV(HY)

Highest at VND 652,275.91 MM

DEBT-EQUITY RATIO (HY)

Lowest at -15.04 %

DEBTORS TURNOVER RATIO(HY)

Highest at 4.82%

-10What is not working for the Company

ROCE(HY)

Lowest at 9.13%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.98%

OPERATING PROFIT(Q)

Lowest at VND 19,971.44 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 8.87 %

PRE-TAX PROFIT(Q)

Lowest at VND 15,876.2 MM

NET PROFIT(Q)

Lowest at VND 12,554.55 MM

EPS(Q)

Lowest at VND 568.51

Here's what is working for Vidipha Central Pharmaceutical JSC

Operating Cash Flow

Highest at VND 203,120.14 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (VND MM)

Cash and Eqv

Highest at VND 652,275.91 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -15.04 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio

Highest at 4.82%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -11.81% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Vidipha Central Pharmaceutical JSC

Operating Profit

Lowest at VND 19,971.44 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (VND MM)

Operating Profit Margin

Lowest at 8.87 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at VND 15,876.2 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (VND MM)

Net Profit

Lowest at VND 12,554.55 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (VND MM)

EPS

Lowest at VND 568.51

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (VND)

Inventory Turnover Ratio

Lowest at 1.98%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio